Completed

A Study of Lasmiditan (LY573144) in Children Aged 6 to 17 With Migraine

H8H-MC-LAHX - ClinicalTrials.gov - NCT03988088

The purpose of the study is the measure the levels of lasmiditan in the body of children aged 6 to 17 with migraine. The study also will also examine the safety and tolerability of lasmiditan in children aged 6 to 17 with migraine.
How long will I be in the trial?
The study will last about 6 weeks, and includes 4 visits.
Email
Completed

A Study of Lasmiditan (LY573144) in Children Aged 6 to 17 With Migraine

H8H-MC-LAHX - ClinicalTrials.gov - NCT03988088

The purpose of the study is the measure the levels of lasmiditan in the body of children aged 6 to 17 with migraine. The study also will also examine the safety and tolerability of lasmiditan in children aged 6 to 17 with migraine.
How long will I be in the trial?
The study will last about 6 weeks, and includes 4 visits.
Email

Key Requirements

Age :

6-17

Sex:

All

Key Requirements

Use the following checklist to help determine if this trial may be a good fit for you. Place a checkmark next to each criteria that you successfully meet.

Age

6-17

Sex

All

Participants must

Participants must have a history of migraine headaches for more than 6 months

Participants must have a history of 2 to 15 migraine headaches per month in the past 2 months

Participants must weigh between 15 and 55 kilograms (kg)

Participants must NOT

Participants must not have a migraine headache on the day of lasmiditan administration

Participants must not be pregnant or nursing

Participants must not have any acute, serious, or unstable medical condition

Participants must not be actively suicidal or at significant risk for suicide, in the opinion of the investigator

Participants must not be on a medicine that acts in the brain and spinal cord

Trial Summary

Conditions the trial is for

Migraine, Pediatric Migraine

What the trial is testing?

Lasmiditan

Could I receive a Placebo?

no

Enrollment Goal

21

Trial Dates

July 2019 - February 2020

Trial Phase

1

Enter your postal code to find the nearest site

Key Requirements

Use the following checklist to help determine if this trial may be a good fit for you. Place a checkmark next to each criteria that you successfully meet.

Age

6-17

Sex

All

Participants must

Participants must have a history of migraine headaches for more than 6 months

Participants must have a history of 2 to 15 migraine headaches per month in the past 2 months

Participants must weigh between 15 and 55 kilograms (kg)

Participants must NOT

Participants must not have a migraine headache on the day of lasmiditan administration

Participants must not be pregnant or nursing

Participants must not have any acute, serious, or unstable medical condition

Participants must not be actively suicidal or at significant risk for suicide, in the opinion of the investigator

Participants must not be on a medicine that acts in the brain and spinal cord

Trial Summary

Conditions the trial is for

Migraine, Pediatric Migraine

What the trial is testing?

Lasmiditan

Could I receive a Placebo?

no

Enrollment Goal

21

Trial Dates

July 2019 - February 2020

Trial Phase

1

Not the right fit? Sign up to receive updates on new trials.

Trial Locations

Hide locations not currently recruiting

Enter your postal code to see sites near you

Resources

Clinical Trial Participation: What to Expect

Clinical Trial Participation: What to Expect

A clinical trial is a scientific study in people that helps to determine if and how a drug or therapy works. These can also be called clinical studies, or clinical research. Clinical research helps us answer specific questions about an investigational drug , such as: Is it effective? Is it more effective than another established treatment? Is it safe and/or what are its side effects?